FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and medicine and presents a composition capable of forming a specific mucoadhesive gelling complex throughout the gastrointestinal tract, containing bacteria capable of producing the exopolysaccharide in situ in the gastrointestinal tract and belonging to at least one of the following strains: Streptococcus thermophilus DSM 16590 (YO2), Streptococcus thermophilus DSM 16592 (YO4), Streptococcus thermophilus DSM 17843 (YO8), Streptococcus thermophilus DSM 25246 (ST10), Streptococcus thermophilus DSM 25247 (ST11), Streptococcus thermophilus DSM 25282 (ST12) together with a tare gum, for use as a medicine for the prevention and treatment of all pathologies, associated with a deficiency of the barrier effect in the gastrointestinal region due to low production of mucus.
EFFECT: invention ensure preservation of sufficient and good viability bacterial strains, as well as preservation of intestinal mucosa.
5 cl, 2 tbl
